BioStack Platforms YCアプリケーション

Spring 2026Active

BioStack PlatformsはSpring 2026バッチでHealthcare企業としてY Combinatorを卒業しました。以下：会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。

YCバッチ: Spring 2026
業界: Healthcare
ステータス: Active
ローンチ済み: 2026

創業者

Sanat MishraFounder
Parth PatwaFounder

BioStack Platformsの事業内容

BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside hospitals, labs, and CROs, while generating new data is slow and expensive. BioStack fixes this with proprietary clinical and preclinical data pipelines that turn real biomedical workflows into ML-ready training environments. We structure longitudinal multimodal data across imaging, EHR, and experimental assays, then package it for post-training and reinforcement learning so models can learn how research and care actually happen. Instead of static datasets, BioStack gives AI labs workflow-aligned data and environments that improve reasoning, decision-making, and real-world performance in biology and medicine.

BioStack PlatformsのYCアプリケーション、再構築済み

Y Combinator 申請

BioStack Platforms 様、Spring 2026 バッチ。公開データから回答された、実際のフォームの質問。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

BioStack Platforms

Describe what your company does in 50 characters or less.

Real world training envs for healthcare AI models

What is your company going to make? Please describe your product and what it does or will do.

We build data pipelines that turn messy, fragmented clinical and experimental biology data into structured, machine learning-ready training environments. Our platform aligns longitudinal multimodal data - from imaging, EHR, and experimental assays - into workflows that reflect actual biomedical research and clinical care. This lets AI models train not just on static datasets but on sequences of real-world biomedical workflows, improving their decision-making and reasoning in healthcare and drug discovery.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and plan to keep the company based here after YC.

Explain your decision regarding location.

San Francisco has the expertise in AI and biotech we need, plus proximity to hospitals and labs where data originates. It gives us the network and talent to build and scale BioStack.

フルアプリケーションで21件の追加回答

はフルバージョンにあります。無料アカウントを作成して、他のすべてのYCバッチの横にあるYCインサイトで開いてください。

申請内容全体を見る

よくある質問

BioStack Platformsの実際のYCアプリケーションですか？

いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、BioStack Platformsの公開データ（ローンチノート、創業者経歴、製品説明）から回答しています。BioStack Platformsのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。